Epinephrine
(Adrenalin, Sus-Phrine)
|
Category:
Description:
Indications:
Contraindications:
-
Cardiac
dysrhythmias, angle-closure glaucoma, local anesthetic of fingers and toes
-
General
anesthesia with halocarbons or cyclopropane, organic brain damage, labor,
coronary insufficiency
Precautions:
-
Pregnancy
category C; excreted in breast milk; use caution in nursing mothers
-
Elderly,
cardiovascular disease, hypertension, diabetes, hyperthyroidism
-
Psychotic
individuals, thyrotoxicosis, parkinsonism
Adverse
Reactions (Side Effects):
-
CNS:
anxiety, dizziness, fear, headache, hemiplegia, subarachnoid hemorrhage,
tremor, weakness, restlessness
-
CV:
anginal pain, dysrhythmias, hypertension, palpitations
-
GI:
nausea, vomiting
-
GU:
urinary retention
-
RESP:
respiratory difficulty
-
SKIN:
hemorrhage at injection site, pallor, urticaria, wheal
|
Dosage:
Administered
topically, intravenously, intramuscularly, subcutaneously, inhalation
-
Adult:
-
Bronchodilator:
-
IM/SC
(1:1000) 0.1-0.5mg every 12-15 minutes up to 4 hours
-
IV 0.1-0.25mg
(single dose max 1mg); SC susp (1:200) 0.5-1.5mg (0.1-0.3 ml)
-
NEB instill
8-15 drops into nebulizer reservoir, administer 1-3 inhalations 4-6 times
daily
-
MDI 1-2 puffs at 1st sign of bronchospasm
-
Cardiac arrest:
-
IV/intracardiac
0.1-1mg (1-10 ml of 1/10,000 dilution) every 3-5 minutes as needed
-
IV
intermediate dose 2-5mg every 3-5 minutes; escalating dose 1-3-5mg 3
minutes apart; high dose 0.1 mg/kg every 3-5 minutes
-
Intratracheal 1mg
every 3-5 minutes (higher doses, eg. 0.1 mg/kg, should be considered only
after 1mg doses have failed
-
Hypotension:
-
Anaphylactic reaction:
-
Glaucoma:
-
Nasal congestion:
-
Child:
-
Bronchodilator:
-
SC 10
mcg/kg (0.1 ml/kg of 1:1000), max single dose 0.5mg
-
Susp (1:200) 0.005
ml/kg/dose (0.025 mg/kg/dose) every 6 hours, max 0.15 ml (0.75mg) per dose
-
NEB 0.25-0.5 ml of 2.25% racemic epinephrine solution diluted in 3
ml NS every 1-4 hours
-
Cardiac arrest:
-
Refractory hypotension:
-
Anaphylactic reaction:
-
Nasal congestion:
-
Neonate:
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|